Technical Analysis for QLGN - Qualigen Therapeutics, Inc.

Grade Last Price % Change Price Change
F 0.10 2.74% 0.00
QLGN closed up 2.74 percent on Monday, November 4, 2024, on 1.95 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 12
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New Downtrend Bearish -98.00%
Doji - Bearish? Reversal -98.00%
Doji - Bullish? Reversal -98.00%
Outside Day Range Expansion -98.00%
Wide Bands Range Expansion -98.00%
Oversold Stochastic Weakness -98.00%
New 52 Week Closing Low Bearish -97.95%
Calm After Storm Range Contraction -97.95%
Narrow Range Bar Range Contraction -97.95%
Lower Bollinger Band Walk Weakness -97.95%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 19 hours ago
2x Volume Pace about 19 hours ago
1.5x Volume Pace about 19 hours ago
Outside Day about 19 hours ago
Up 5% about 19 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Qualigen is a biotechnology company focused on developing novel products for the treatment and testing of cancer and infectious diseases. Its current commercial product is the FastPack rapid diagnostic testing system. This "Laboratory in a Pouch" is installed in physician offices, clinics and small hospitals around the world, and quickly detects diseases and medical conditions at the point-of-care. Since its inception almost 20 years ago, FastPack has generated more than $100 million in commercial sales. Qualigen's worldwide distributor for FastPack is Sekisui Diagnostics, a subsidiary of a multibillion-dollar Japanese chemical and technology company. Sekisui owns approximately 15.8% of Qualigen's outstanding common shares.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical Disease Infectious Diseases Clinic Medical Test Novel Products

Is QLGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 39.13
52 Week Low 3.755
Average Volume 69,026
200-Day Moving Average 14.17
50-Day Moving Average 8.03
20-Day Moving Average 7.15
10-Day Moving Average 6.00
Average True Range 1.19
RSI (14) 30.07
ADX 25.03
+DI 13.55
-DI 24.14
Chandelier Exit (Long, 3 ATRs) 6.90
Chandelier Exit (Short, 3 ATRs) 7.31
Upper Bollinger Bands 10.26
Lower Bollinger Band 4.05
Percent B (%b) 0.16
BandWidth 86.85
MACD Line -0.97
MACD Signal Line -0.70
MACD Histogram -0.27
Fundamentals Value
Market Cap 26.19 Million
Num Shares 5.18 Million
EPS -4.07
Price-to-Earnings (P/E) Ratio -1.24
Price-to-Sales 0.56
Price-to-Book 0.35
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.61
Resistance 3 (R3) 7.63 6.80 7.19
Resistance 2 (R2) 6.80 6.15 6.79 7.04
Resistance 1 (R1) 5.93 5.74 6.36 5.91 6.90
Pivot Point 5.09 5.09 5.31 5.08 5.09
Support 1 (S1) 4.22 4.44 4.66 4.20 3.21
Support 2 (S2) 3.39 4.04 3.38 3.07
Support 3 (S3) 2.52 3.39 2.92
Support 4 (S4) 2.50